| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |